Meeting
2020 ASCO Virtual Scientific Program
Effect of early integration of specialized palliative care into standard oncologic treatment on the quality of life of patients with advanced head and neck cancers: A phase III randomized controlled trial.
Authors
Pankaj Singhai
Tata Memorial Centre, Mumbai, India
Pankaj Singhai , Vijay Maruti Patil , Mary Ann Muckaden , Jayita Deodhar , Naveen Salins , Vanita Noronha , Amit Joshi , Nandini Sharrel Menon , Ashwini Khake , Sachin Babanrao Dhumal , Kumar Prabhash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
CTRI/2016/03/006693
Citation
J Clin Oncol 38: 2020 (suppl; abstr 12013)
DOI
10.1200/JCO.2020.38.15_suppl.12013
Abstract #
12013
Poster Bd #
301
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Endpoints reported in phase 3 randomized clinical trials at ASCO 2022.
First Author: Laure-Anne Marie Nicole Teuwen
Poster
2022 ASCO Annual Meeting
Phase III randomized controlled trial comparing chemotherapy to best supportive care in advanced esophageal and gastroesophageal junction cancer.
First Author: Vanita Noronha
Poster
2021 ASCO Annual Meeting
Effectiveness of a nurse-led, screening-triggered, early specialized palliative care intervention program for patients with advanced lung cancer: A multicenter randomized controlled trial.
First Author: Yoshihisa Matsumoto
Poster
2016 ASCO Annual Meeting
Quality of life (QoL) and overall survival (OS) in patients (pts) with advanced clear-cell renal cell carcinoma (aRCC) treated with nivolumab (NIVI) vs. everolimus (EVE) in the phase III CheckMate 025 study.
First Author: David Cella